- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01502839
Role of NSI in Differentiating Between Mild Traumatic Brain Injury And Behavioral Health Conditions
Differentiating Between Mild Traumatic Brain Injury And Behavioral Health Conditions: The Role of The Neurobehavioral Symptom Inventory
The purpose of this study is to examine differences in post-concussive (PC) symptom endorsement among four groups of Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans: those with a history of target, service-related, mild traumatic brain injury (mTBI) and co-occurring posttraumatic stress disorder (PTSD) (Group 1); those with a history of target, service-related, mTBI only (Group 2); those with PTSD only (Group 3); and those with no history of target, service-related, mTBI or PTSD (Group 4) by examining scores on the Neurobehavioral Symptom Inventory (NSI). Support for this study is provided by previous research highlighting the complex relationship between mTBI, PTSD and subsequent PC symptom endorsement (Brenner et al. 2010; Terrio et al, 2009).
HYPOTHESES ARE AS FOLLOWS:
- Individuals with a history of target, service-related, mTBI only (Group 2) and individuals with PTSD only (Group 3) each will report significantly more PC symptoms, as measured by NSI total scores, when compared to those with no history of service-related mTBI or PTSD (Group 4).
- Individuals with co-occurring target, service-related, mTBI history and PTSD (Group 1) will report significantly more PC symptoms, as measured by total NSI scores, than either those with target, service-related, mTBI only (Group 2) or those with PTSD only (Group 3).
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Archival data will be collected from all OEF/OIF Veterans who were seen in the VA ECHCS TBI Clinic by Nancy Cutter, M.D. and her team between January 1, 2009 and December 31, 2010. Electronic Medical Record (EMR) progress note titles "OEF/OIF TBI 2nd Level Evaluation Consult Report" and "TBI Consult Report" will be used to identify potential subjects.
Power is based on the primary hypothesis that those with PTSD only (Group 3) and those with target, service-related mTBI only (Group 2) will have significantly more PC symptom reporting than those with no history of target, service-related mTBI or PTSD (Group 4). Belanger et al. (2010) reported a standard deviation of 15.3 on the NSI total score in a sample of 134 mTBI subjects. Assuming variability similar to the Belanger study, a significance level of 0.025 to correct for the two comparisons and 80% power, 180 subjects per group will detect a clinically significant difference of 5 points. For simplicity, this was calculated using a two-sided, two-sample t-test. Given that we are modeling all four groups together, pooled standard error estimates will be used, which will result in slightly higher power.
All analyses will assume a two-sided test of hypothesis with an overall significance level of 0.05, unless otherwise noted, and will be performed in either Statistical Analysis Software (SAS) v9.2 or above (SAS Institute, Inc., Cary, NC).
Demographic characteristics will be reported as means and standard deviations; medians and ranges; and proportions, as appropriate. Likewise, characteristics will be compared between the four aforementioned subject groups using Analysis of Variance (ANOVA), chi-square tests and/or nonparametric tests as appropriate.
Hypothesis 1: An ANOVA with reference cell coding will be utilized to model NSI total score as a function of the four groups (Group 1: Individuals with co-occurring target, service-related, mTBI and PTSD; Group 2: those with target, service-related, mTBI only; Group 3: those with PTSD only; and Group 4: those with no history of target, service-related, mTBI or PTSD). Potential confounders will then be assessed individually by adding them to the model with the groups. If any of the group parameter estimates changes by more than 10% with the inclusion of the potential confounder, the variable will be utilized in the final model. Once the final model is determined, a contrast will be set up within the model to test (1) PTSD only vs. Neither and (2) target, service-related, mTBI only vs. Neither, a Bonferroni correction will be employed such that the significance level will be adjusted to 0.025 for these two primary tests. Estimated mean differences will be reported with 95% CIs. Potential confounding variables to be considered are: age; gender; total number of deployments; time since last deployment; time since earliest documented mTBI; time since target, service-related, mTBI; and total number of mTBIs.
Hypothesis 2: Within the same final model above, a contrast will be used to test (1) those with co-occurring target, service-related, mTBI and PTSD vs. PTSD only and (2) those with co-occurring target, service-related, mTBI and PTSD vs. target, service-related, mTBI only.
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
Colorado
-
Denver, Colorado, Spojené státy, 80220
- VA Eastern Colorado Health Care System
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion criteria for all groups includes:
- Veteran must be between the ages of 18 to 60
- Veteran must have at least one OEF/OIF deployment
- Veteran must have received an OEF/OIF TBI 2nd Level Evaluation though the VA ECHCS TBI Clinic
Specific inclusion/exclusion criteria for each group are as follows:
Inclusion Criteria:
Group 1: (Both) Co-Occurring PTSD and target, service-related, mTBI
PTSD:
- Clinician confirmed PTSD diagnosis and continuous documentation of symptoms related to PTSD diagnosis within 1 year prior to being seen in the TBI Clinic, or
- Clinician confirmed PTSD diagnosis within 1 year prior to being seen in the TBI Clinic, or
- Clinician confirmed PTSD diagnosis within 60 days after being seen in TBI Clinic
- Target, service-related, mTBI
- Veterans with clinician confirmed target, service-related, mTBI per OEF/OIF TBI 2nd Level Evaluation Consult Report note in EMR
Group 2: (mTBI only) History of target, service-related, mTBI but with no diagnosis of PTSD
- PTSD:
- Veterans with no history of clinician confirmed PTSD diagnosis, or
- Veterans with previous clinician confirmed PTSD diagnosis , but without continuous documentation of PTSD symptoms within 1 year prior to being seen in the TBI clinic
- Target, service-related, mTBI
- Veterans with clinician confirmed target, service-related, mTBI per OEF/OIF TBI 2nd Level Evaluation Consult Report note in EMR
Group 3: (PTSD only) No history of target, service-related, mTBI but with a diagnosis of PTSD
- PTSD:
- Clinician confirmed PTSD diagnosis and continuous documentation of symptoms related to PTSD diagnosis within 1 year prior to being seen in the TBI Clinic, or
- Clinician confirmed PTSD diagnosis within 1 year prior to being seen in the TBI Clinic, or
- Clinician confirmed PTSD diagnosis within 60 days of being seen in TBI Clinic
- TBI:
- Veterans with no history of clinician confirmed diagnosis of target, service-related, mTBI
- Veterans with clinician confirmed mTBI prior to service and without continuous documentation of related symptoms within 1 year of being seen in the TBI Clinic
Group 4: (Neither) No history of target, service-related, mTBI and no diagnosis of PTSD
- PTSD:
- Veterans with no history of clinician confirmed PTSD diagnosis, or
- Veterans with previous clinician confirmed PTSD diagnosis , but without continuous documentation of PTSD symptoms within 1 year of being seen in the TBI clinic
- TBI:
- Veterans with no clinician confirmed diagnosis of target, service-related, mTBI
Exclusion Criteria:
- Those not meeting inclusion criteria as listed above, and
- Veterans with any history of clinician confirmed moderate or severe TBI, and
- Veterans with no NSI in TBI Consult Report note in EMR
- Veterans with documentation of any neurological event or disorder other than mTBI
- Veterans with positive brain imaging
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: Kohorta
- Časové perspektivy: Retrospektivní
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
---|---|
OEF/OIF Veterans
Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans
|
This retrospective data analysis will rely on data obtained from chart review.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Neurobehavioral Symptom Inventory
Časové okno: 1 day (NSI was administered 1 time during clinical visit and documented in EMR as described below)
|
The Neurobehavioral Symptom Inventory (NSI; Cicerone & Kalmar, 1995)is a 22-item self-report measure of PC symptoms recommended for use among military personnel by the Department of Defense (DoD). Subject responses to all 22 items will be extracted from each subject's TBI Consult Report note provided in her/his Electronic Medical Record (EMR). Estimated time to collect all data from this retrospective chart review is 1 year. |
1 day (NSI was administered 1 time during clinical visit and documented in EMR as described below)
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Gina Signoracci, Ph.D., VA Eastern Colorado Health Care System
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Duševní poruchy
- Onemocnění mozku
- Onemocnění centrálního nervového systému
- Nemoci nervového systému
- Kraniocerebrální trauma
- Trauma, nervový systém
- Trauma a poruchy související se stresem
- Poranění hlavy, uzavřeno
- Rány, Nepenetrující
- Poranění mozku
- Stresové poruchy, traumatické
- Stresové poruchy, posttraumatické
- Rány a zranění
- Poranění mozku, traumatické
- Postotřesový syndrom
- Otřes mozku
Další identifikační čísla studie
- 11-0219
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Traumatické zranění mozku
-
The Hong Kong Polytechnic UniversityDokončenoMrtvice | Rozhraní Brain ComputerHongkong
-
Wright State UniversityZatím nenabírámeBolest hlavy | Bolest hlavy vyvolaná chladem | Brain Freeze | Cephalgie vyvolaná chladem
-
Neurolutions, Inc.Washington University School of MedicineZatím nenabírámeMrtvice | Hemiparéza | Spasticita jako pokračování mrtvice | Rozhraní Brain ComputerSpojené státy
Klinické studie na No Intervention
-
CSA Medical, Inc.UkončenoBarrettův jícen | Dysplazie nízkého stupně | Dysplazie vysokého stupněSpojené státy
-
University of PittsburghNational Institute of Mental Health (NIMH)NáborSebevražda | ÚmrtíSpojené státy
-
Otsuka Pharmaceutical Factory, Inc.CelerionDokončeno
-
Oregon Research InstituteDokončenoZneužívání návykových látekSpojené státy
-
Sarah BlaylockVA Office of Research and DevelopmentDokončenoPodzim | Nízké viděníSpojené státy
-
VA Office of Research and DevelopmentDokončenoRakovina tlustého střevaSpojené státy
-
University of Illinois at Urbana-ChampaignDokončenoStárnutí | Mírná kognitivní porucha | Dobře stárnoutSpojené státy
-
Brigham and Women's HospitalNational Institute on Aging (NIA)DokončenoRevmatická onemocnění | Lupus erythematodes, systémový | Adherence, léky | DnaSpojené státy
-
Idaho State UniversityZatím nenabírámeExperimentální videohry | Hodnocení chování